Monthly Archives: February 2013

‘If I had not received the support of UNISON and Thompsons I would be worse now.’ Continue reading

‘This test adds diagnostic value. And the beauty of the race,’ adds Dr. It eliminates the need for more expensive tests and IV exercise testing more difficult.’ Continue reading

‘Our institute has worked to develop this technology to answer a fundamental question about cancer. These results show that the interactions of a DNA sequence of a genome scale can explain some inconsistencies in previous studies. This work will pave the way for the development of highly specific anti-hormone treatment of breast cancer, ‘said Edison Liu, MD, Executive Director of GIS, one of the research institutes sponsored by the Agency of Singapore for Science, Technology and Research . Continue reading

In 2007, two residents of Baltimore City accounted for more than 60 emergency calls, another resident has 110 to 911 calls, and another in 147 of these calls, investigators say. Each call to 911 EMS calls to send an ambulance to the caller. Continue reading

Treatment with Tamiflu for swine flu patients at risk for serious flu complications due to underlying disease. Continue reading

Responding to the BBC article on Clinical Excellence Awards, Bill McMillan, Chief Medical Compensation and the workforce at NHS Employers, said: ‘The current clinical excellence awards scheme is expensive, heavy and in step with the other payment systems in the NHS and we fully support the forthcoming review. Continue reading

The rats that got curcumin showed more resistance to heart failure and inflammation than comparison groups of rats that received curcumin. Continue reading

This result comes from 50 years of consumption data reported by 8,600 white adults in Framingham, Massachusetts, home to a long-term health study. Continue reading

The TAXUS Element Stent is evaluated in the PERSEUS trial, which reported the results of 12 months in March 2009, demonstrating the safety and efficacy of positive results in workhorse lesions for the TAXUS Element Stent System compared to the TAXUS Express2. The PERSEUS clinical program compared the TAXUS Element Stent Boston Scientific’s first generation in over 1600 patients in two trials simultaneously in 90 centers worldwide. Continue reading

Multimeric-001 vaccine was safe and well tolerated, thus satisfying the first point of the study. No vaccine-related serious adverse events were found in one of the participants, and there was no significant difference between treatment groups and control. These results further reinforce the favorable safety profile of the vaccine multimeric-001 reported in phase I / II trials League. Continue reading